Eton Pharmaceuticals (ETON) Financials: Revenue & Earnings
ETON$51.28+0.12 +0.23%
$1.47B
Market Cap
107.89
P/E
47.18
Forward P/E
—
Score
Eton Pharmaceuticals (ETON) Financials: Revenue & Earnings
ETON price $51.28 +0.12 +0.23%
- Ticker
- ETON
- Price
- $51.28
- Change
- +0.12 +0.23%
- Market cap ?
- $1.47B
- P/E ?
- 107.89
- Forward P/E ?
- 47.18
- Dividend yield ?
- 0.00%
- Beta ?
- 0.90
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 959000 | 39000 | 21832000 | 21251000 | 31642000 | 39011000 | 79950000 |
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate…
Fair value
ETON fair value $35.52. Price $51.28. Price is 44% above fair value.
Above fair value, and more expensive than usual. A larger premium than on 64% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Average free cash flow, last three years 5.72M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.25% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 28.58M. Net debt 5.08M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | 0.31 | — | 41.98M |
| 2026-08-13 | 0.35 | 0.19 | 37.59M | 27.11M |
| 2026-05-14 | 0.05 | 0.10 | 24.27M | 22.31M |
| 2026-03-19 | 0.05 | 0.12 | 21.28M | 19.98M |
| 2025-11-06 | -0.07 | 0.16 | 22.46M | 20.47M |
| 2025-08-07 | -0.10 | -0.01 | 18.93M | 20.47M |
| 2025-05-13 | 0.07 | 0.09 | 17.28M | 15.13M |
| 2025-03-18 | -0.02 | -0.02 | 11.65M | 14.33M |
| 2024-11-12 | 0.02 | 0.00 | 10.32M | 10.53M |
| 2024-08-08 | -0.12 | -0.07 | 9.07M | 9.69M |
| 2024-05-09 | -0.03 | -0.07 | 7.97M | 8.80M |
| 2024-03-14 | -0.09 | -0.04 | 7.31M | 7.70M |
| 2023-11-09 | -0.02 | -0.10 | 7.03M | 6.26M |
| 2023-08-10 | 0.15 | -0.09 | 12.00M | 10.09M |
| 2023-05-11 | -0.10 | -0.14 | 5.30M | 6.51M |
| 2023-03-16 | 0.04 | 0.01 | 8.50M | 4.56M |
| 2022-11-10 | -0.12 | -0.15 | 3.22M | 3.05M |
| 2022-08-11 | -0.06 | -0.01 | 7.36M | 7.80M |
| 2022-05-12 | -0.21 | -0.08 | 2.18M | 2.04M |
| 2022-03-16 | 0.04 | 0.19 | 6.09M | — |
| 2021-11-15 | -0.24 | -0.14 | 775.00K | 663.96K |
| 2021-08-16 | -0.08 | -0.14 | 3.07M | 4.76M |
| 2021-05-13 | 0.19 | 0.19 | 11.90M | 12.05M |
| 2021-03-16 | -0.32 | -0.26 | 81.00K | — |
| 2020-11-12 | -0.31 | -0.26 | 161.00K | — |
| 2020-08-12 | -0.23 | -0.28 | 20.00K | 22.61K |
| 2020-05-14 | -0.50 | -0.24 | 99.00K | 66.83K |
| 2020-03-05 | -0.15 | -0.29 | 459.00K | 795.60K |
| 2019-11-14 | -0.28 | -0.23 | — | 446.43K |
| 2019-08-06 | -0.18 | -0.30 | — | 777.78K |
| 2019-05-07 | -0.42 | — | 500.00K | — |
| 2019-03-25 | -2.24 | — | — | — |
| 2018-12-20 | -0.52 | — | — | — |
| 2018-06-30 | -0.55 | — | — | — |
| 2018-03-31 | -0.54 | — | — | — |
| 2017-12-31 | -2.01 | — | — | — |
| 2017-09-30 | -0.50 | — | — | — |
| 2017-06-30 | -0.69 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Krempa David | Sell | 4.17K | $55.07 | 229.41K |
| 2026-10-02 | Krempa David | Buy | 10.52K | — | — |
| 2026-10-02 | Krempa David | Sell | 10.52K | — | — |
| 2026-08-28 | MAIER PAUL V | Buy | 12.50K | $7.31 | 91.38K |
| 2026-08-28 | MAIER PAUL V | Buy | 12.50K | $7.31 | 91.38K |
| 2026-08-28 | MAIER PAUL V | Buy | 50.00K | $3.78 | 189.00K |
| 2026-08-28 | MAIER PAUL V | Sell | 36.39K | $58.64 | 2.13M |
| 2026-08-28 | MAIER PAUL V | Sell | 13.48K | $60.21 | 811.93K |
| 2026-08-28 | MAIER PAUL V | Sell | 128 | $61.77 | 7.91K |
| 2026-08-28 | MAIER PAUL V | Sell | 50.00K | $3.78 | 189.00K |
| 2026-08-24 | Krempa David | Sell | 25.00K | $7.31 | 182.75K |
| 2026-08-24 | Krempa David | Buy | 25.00K | $7.31 | 182.75K |
| 2026-08-24 | Krempa David | Sell | 25.00K | $65.07 | 1.63M |
| 2026-08-20 | BRYNJELSEN SEAN | Sell | 47.31K | $60.17 | 2.85M |
| 2026-08-20 | BRYNJELSEN SEAN | Sell | 36.37K | $61.11 | 2.22M |
| 2026-08-20 | BRYNJELSEN SEAN | Sell | 7.34K | $62.12 | 456.09K |
| 2026-08-19 | BRYNJELSEN SEAN | Sell | 8.98K | $62.65 | 562.47K |
| 2026-07-31 | Radosavljevic Danka | Other | 0 | — | — |
| 2026-07-31 | Radosavljevic Danka | Other | 31.51K | $15.47 | 487.43K |
| 2026-07-31 | Radosavljevic Danka | Other | 7.19K | — | — |
| 2026-07-31 | Radosavljevic Danka | Other | 14.32K | $13.00 | 186.12K |
| 2026-07-31 | Radosavljevic Danka | Other | 10.00K | $14.68 | 146.80K |
| 2026-07-31 | Radosavljevic Danka | Other | 92.99K | $4.42 | 411.03K |
| 2026-07-31 | Radosavljevic Danka | Other | 10.00K | $4.74 | 47.40K |
| 2026-07-31 | Radosavljevic Danka | Other | 42.22K | $3.47 | 146.52K |
| 2026-07-31 | Radosavljevic Danka | Other | 35.00K | $8.61 | 301.35K |
| 2026-07-31 | Radosavljevic Danka | Other | 60.00K | $3.58 | 214.80K |
| 2026-07-31 | Radosavljevic Danka | Other | 18.74K | $1.38 | 25.86K |
| 2026-07-31 | Radosavljevic Danka | Other | 128.99K | — | — |
| 2026-07-31 | CASAMENTO CHARLES J | Buy | 10.00K | — | — |
| 2026-07-31 | Matthews Judith M. | Buy | 32.25K | — | — |
| 2026-07-31 | Erdogan-Trinkaus Ipek | Buy | 80.00K | — | — |
| 2026-07-31 | BRYNJELSEN SEAN | Buy | 128.99K | — | — |
| 2026-07-31 | Krempa David | Buy | 128.99K | — | — |
| 2026-07-31 | MAIER PAUL V | Buy | 10.00K | — | — |
| 2026-07-31 | RIEDEL NORBERT G | Buy | 10.00K | — | — |
| 2026-07-31 | Adams Jennifer McKie | Buy | 10.00K | — | — |
| 2026-07-14 | Opaleye Management Inc. | Sell | 15.00K | $37.54 | 563.15K |
| 2026-07-14 | Opaleye Management Inc. | Sell | 13.31K | $37.54 | 499.89K |
| 2026-07-14 | Opaleye Management Inc. | Sell | 15.00K | $37.54 | 563.15K |
| 2026-07-14 | Opaleye Management Inc. | Sell | 13.31K | $37.54 | 499.89K |
| 2026-07-14 | BRYNJELSEN SEAN | Buy | 200.00K | $1.37 | 274.00K |
| 2026-07-14 | BRYNJELSEN SEAN | Buy | 200.00K | $1.37 | 274.00K |
| 2026-07-12 | BRYNJELSEN SEAN | Buy | 27.50K | — | — |
| 2026-07-12 | BRYNJELSEN SEAN | Sell | 27.50K | — | — |
| 2026-07-12 | Krempa David | Buy | 10.00K | — | — |
| 2026-07-12 | Krempa David | Sell | 10.00K | — | — |
| 2026-07-07 | Opaleye Management Inc. | Sell | 20.00K | $38.37 | 767.46K |
| 2026-07-07 | Opaleye Management Inc. | Sell | 6.68K | $38.37 | 256.52K |
| 2026-07-06 | Opaleye Management Inc. | Sell | 10.00K | $38.00 | 380.00K |
| 2026-07-02 | Opaleye Management Inc. | Sell | 65.00K | $37.39 | 2.43M |
| 2026-07-02 | Opaleye Management Inc. | Sell | 25.00K | $37.39 | 934.63K |
| 2026-06-26 | Krempa David | Buy | 10.00K | — | — |
| 2026-06-17 | Adams Jennifer McKie | Buy | 50.00K | $3.78 | 189.00K |
| 2026-06-17 | Adams Jennifer McKie | Sell | 50.00K | $3.78 | 189.00K |
| 2026-06-17 | Adams Jennifer McKie | Sell | 50.00K | $32.48 | 1.62M |
| 2026-06-01 | Matthews Judith M. | Other | 37.00K | $26.05 | 963.85K |
| 2026-05-28 | BRYNJELSEN SEAN | Sell | 119.85K | $31.88 | 3.82M |
| 2026-05-28 | BRYNJELSEN SEAN | Sell | 148 | $32.67 | 4.84K |
| 2026-05-27 | Krempa David | Sell | 7.20K | $3.58 | 25.79K |
| 2026-05-27 | Krempa David | Buy | 7.20K | $3.58 | 25.79K |
| 2026-05-27 | Krempa David | Buy | 12.48K | $1.37 | 17.09K |
| 2026-05-27 | Krempa David | Sell | 19.68K | $31.47 | 619.37K |
| 2026-05-27 | Krempa David | Sell | 12.48K | $1.37 | 17.09K |
| 2026-05-26 | Krempa David | Buy | 12.52K | $1.37 | 17.16K |
| 2026-05-26 | Krempa David | Buy | 25.00K | $1.38 | 34.50K |
| 2026-05-26 | Krempa David | Sell | 37.52K | $31.49 | 1.18M |
| 2026-05-26 | Krempa David | Sell | 12.52K | $1.37 | 17.16K |
| 2026-05-26 | Krempa David | Sell | 25.00K | $1.38 | 34.50K |
| 2026-05-22 | Krempa David | Sell | 30.59K | $3.58 | 109.52K |
| 2026-05-22 | Krempa David | Buy | 30.59K | $3.58 | 109.52K |
| 2026-05-22 | Krempa David | Sell | 32.96K | $33.22 | 1.10M |
| 2026-05-22 | Krempa David | Sell | 9.31K | $33.88 | 315.59K |
| 2026-05-22 | Krempa David | Sell | 519 | $35.00 | 18.16K |
| 2026-04-21 | RIEDEL NORBERT G | Buy | 19.66K | $8.61 | 169.23K |
| 2026-04-21 | RIEDEL NORBERT G | Buy | 12.50K | $7.31 | 91.38K |
| 2026-04-21 | RIEDEL NORBERT G | Sell | 19.66K | $8.61 | 169.23K |
| 2026-04-21 | RIEDEL NORBERT G | Sell | 12.50K | $7.31 | 91.38K |
| 2026-02-03 | RIEDEL NORBERT G | Buy | 30.00K | $4.42 | 132.60K |
| 2026-02-03 | RIEDEL NORBERT G | Sell | 30.00K | $4.42 | 132.60K |
| 2026-01-14 | Krempa David | Sell | 1.94K | $15.62 | 30.33K |
| 2026-01-14 | Gruber James R. | Sell | 2.29K | $15.47 | 35.47K |
| 2026-01-12 | RIEDEL NORBERT G | Buy | 7.76K | — | — |
| 2026-01-12 | RIEDEL NORBERT G | Buy | 12.20K | $15.47 | 188.67K |
| 2026-01-12 | Adams Jennifer McKie | Buy | 7.76K | — | — |
| 2026-01-12 | Adams Jennifer McKie | Buy | 12.20K | $15.47 | 188.67K |
| 2026-01-12 | CASAMENTO CHARLES J | Buy | 7.76K | — | — |
| 2026-01-12 | CASAMENTO CHARLES J | Buy | 12.20K | $15.47 | 188.67K |
| 2026-01-12 | MAIER PAUL V | Buy | 7.76K | — | — |
| 2026-01-12 | MAIER PAUL V | Buy | 12.20K | $15.47 | 188.67K |
| 2026-01-12 | Erdogan-Trinkaus Ipek | Buy | 25.86K | — | — |
| 2026-01-12 | Erdogan-Trinkaus Ipek | Buy | 40.66K | $15.47 | 628.93K |
| 2026-01-12 | BRYNJELSEN SEAN | Buy | 100.52K | — | — |
| 2026-01-12 | BRYNJELSEN SEAN | Buy | 158.05K | $15.47 | 2.44M |
| 2026-01-12 | Krempa David | Buy | 25.86K | — | — |
| 2026-01-12 | Krempa David | Buy | 40.66K | $15.47 | 628.93K |
| 2026-01-12 | Gruber James R. | Buy | 25.86K | — | — |
| 2026-01-12 | Gruber James R. | Buy | 40.66K | $15.47 | 628.93K |
| 2026-01-01 | BRYNJELSEN SEAN | Sell | 5.01K | $15.39 | 77.18K |
| 2025-12-12 | Erdogan-Trinkaus Ipek | Sell | 85 | $16.90 | 1.44K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 172, holders +51 vs prior quarter. Ownership 72.51%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 2.86M | 0 | 0.00% | 103.53M |
| ECOR1 CAPITAL, LLC | 2.17M | 0 | 0.00% | 78.62M |
| BLACKROCK, INC. | 1.90M | 178.55K | +10.40% | 68.63M |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 1.18M | 0 | 0.00% | 42.57M |
| VANGUARD CAPITAL MANAGEMENT LLC | 976.57K | -17.52K | -1.76% | 35.35M |
| MORGAN STANLEY | 767.97K | 290.01K | +60.68% | 27.80M |
| STATE STREET CORP | 701.79K | 171.57K | +32.36% | 25.40M |
| GEODE CAPITAL MANAGEMENT, LLC | 652.30K | 74.64K | +12.92% | 23.62M |
| OBERWEIS ASSET MANAGEMENT INC/ | 501.60K | 62.30K | +14.18% | 18.16M |
| NATIONAL PHILANTHROPIC TRUST | 492.11K | 0 | 0.00% | 17.81M |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 431.16K | -36.76K | -7.86% | 15.61M |
| PILLSBURY LAKE CAPITAL LLC | 387.16K | 22.20K | +6.08% | 14.02M |
| NUVEEN, LLC | 375.71K | 317.76K | +548.33% | 13.60M |
| BNP PARIBAS FINANCIAL MARKETS | 322.47K | 20.36K | +6.74% | 11.67M |
| WOODLINE PARTNERS LP | 310.88K | 140.18K | +82.12% | 11.25M |
| THOMPSON SIEGEL & WALMSLEY LLC | 297.23K | -108.86K | -26.81% | 10.76M |
| NORTHERN TRUST CORP | 255.85K | 18.02K | +7.58% | 9.26M |
| MARSHALL WACE, LLP | 249.18K | 166.46K | +201.23% | 9.02M |
| PANORAMIC CAPITAL, LLC | 208.19K | 23.19K | +12.54% | 7.54M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 194.59K | 42.84K | +28.23% | 7.04M |
| JPMORGAN CHASE & CO | 191.63K | 21.76K | +12.81% | 7.04M |
| D. E. SHAW & CO., INC. | 188.45K | 188.45K | New | 6.82M |
| JANE STREET GROUP, LLC | 185.70K | 168.40K | +973.39% | 6.72M |
| LUMBARD & KELLNER, LLC | 175.91K | -2 | -0.00% | 6.37M |
| CANNELL CAPITAL LLC | 170.75K | -171.24K | -50.07% | 6.18M |
Earnings and financials
Eton Pharmaceuticals, Inc. (ETON) trades at $51.28, with a market cap of $1.47B and a trailing P/E of 107.89. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 959000 | 39000 | 21832000 | 21251000 | 31642000 | 39011000 | 79950000 |
Insights · Dividends · Forecast · Financials · Learn